Comparative PET Imaging for Radiosurgical Target Delineation in Residual Acromegaly
PET imaging is increasingly recognized as a valuable tool for localizing pituitary tumors. Currently, l-[methyl-11C]methionine ([11C]Met) is the most extensively studied for this purpose ([1][1]), although there is increasing interest in tracers such as O -(2-18F-fluoroethyl)-l-tyrosine ([18F]FET
Authors
- Mark Gurnell
- Daniel Zips (ORCID: https://orcid.org/0000-0001-5779-9675)
- Peter Vajkoczy (ORCID: https://orcid.org/0000-0003-4350-392X)
- L. Richter
- Matthias Pirlich
- Knut Mai (ORCID: https://orcid.org/0000-0003-0126-3155)
- James MacFarlane (ORCID: https://orcid.org/0000-0001-6937-2775)
- Leah M. Hesse (ORCID: https://orcid.org/0009-0002-9578-011X)
- Vanessa Hubertus (ORCID: https://orcid.org/0000-0002-2653-5818)
- Jonathan Jones (ORCID: https://orcid.org/0000-0002-1496-4922)
- Christian J. Strasburger (ORCID: https://orcid.org/0000-0001-7905-7357)
- Lukas Maurer (ORCID: https://orcid.org/0000-0002-5813-7910)
- Carolin Senger (ORCID: https://orcid.org/0000-0001-7700-4657)
- Sophie Howarth (ORCID: https://orcid.org/0000-0001-7169-2356)
- Linus Haberbosch (ORCID: https://orcid.org/0000-0002-4464-0427)
- Daniel Gillett (ORCID: https://orcid.org/0000-0002-9773-6502)
- Güliz Acker (ORCID: https://orcid.org/0000-0002-8946-6426)
Institutions
- Addenbrooke's Hospital (GB)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2025-11-25
- DOI
- https://doi.org/10.2967/jnumed.125.270365
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00